期刊文献+

新型腹膜透析液的研究进展 被引量:5

Research progress in new peritoneal dialysis fluid
下载PDF
导出
摘要 腹膜透析液是腹膜透析治疗不可或缺的重要组成部分。研发能够达到充分透析治疗目的、生物相容性好、具有腹膜保护功能并可改善患者生活质量和临床结局的腹膜透析液是新型腹膜透析液研究的目的。本文就目前新型腹膜透析液的研究进展作一综述。 Peritoneal dialysis(PD) fluid is an indispensable part of PD. New PD dialysate is required to have better dialysis function, biocompatibility and protection of peritoneal function to improve quality of life and prognosis of PD patients. This paper summarizes the research progress in new peritoneal dialysis fluid.
作者 郭红霞 唐雯 GUO Hong-xia;TANG Wen(Department of Nephrology,Peking University Third Hospital,Beijing 100191,China)
出处 《中国血液净化》 CSCD 2020年第6期403-405,409,共4页 Chinese Journal of Blood Purification
基金 北大医学交叉研究种子基金(项目编号:BMU2020MI010) 中华医学会临床医学科研专项资金项目(14050460583)。
关键词 腹膜透析液 艾考糊精 腹膜透析 糖降解产物 生物相容性 Peritoneal dialysis fluid Icodextrin Peritoneal dialysis Glucose degradation product Biocompatibility
  • 相关文献

参考文献1

二级参考文献29

  • 1Johnson DW, Clarke M, Wilson V, et al. Rationale and design of thebalANZ trial : a randomised controlled trial of low GDP, neutral pH versus standard peritoneal dialysis solution for the preservation of residual renal function.BMC Nephrol,2010,11:25.
  • 2Perl J, Nessim S J, Bargman JM. The bioeompatibility of neutral pH, low-GDP peritoneal dialysis solutions: benefit at bench, bedside, or both? Kidney Int, 2011,79 (8) : 814-824.
  • 3Cho Y, Badve SV, Hawley CM, et al.Biocompatible peritoneal dialysis fluids: clinical outcomes.Int J Nephrol, 2012,2012 : 812609.
  • 4Cho KH, Do JY, Park JW, et al. The effect of low-GDP solution on ultrafiltration and so]nte transport in continuous ambulatory peritoneal dialysis patients.Petit Dial Int,2013,33 (4) : 382-390.
  • 5Park SH,Do JY,Kim YH,et al.Effeets of neutral pH and low-glucose degradation product-containing peritoneal dialysis fluid on systemic markers of inflammation and endothelial dysfunction: A randomized controlled 1-year follow-up study. Nephrol Dial Transplant, 2012,27 (3) :1191-1199.
  • 6Lui SL, Yung S, Yim A, et al. A combination of biocompatible peritoneal dialysis solutions and residual renal function, peritoneal transport, and inflammation markers : A randomized clinical trial.Am J Kidney Dis,2012,60(6) :966-975.
  • 7Lai KN, Lain MF, Leung JC, et al. A study of the clinical and biochemical profile of peritoneal dialysis fluid low in glucose degradation products.Petit Dial Int, 2012,32 (3) :280-291.
  • 8Kim S,Oh KH, Oh J, et al. Biocompatible peritoneal dialysis solution preserves residual renal function. Am J Nephrol, 2012, 36 ( 4 ) : 305-316.
  • 9Johnson DW, Brown FG, Clarke M, et al. Effects of biocompatible versus standard fluid on peritoneal dialysis outcomes. J Am Soc Nephrol,2012,23(6) : 1097-1107.
  • 10Johnson DW, Brown FG, Clarke M, et al.The effects of biocornpatible compared with standard peritoneal dialysis solutions on peritonitis microbiology, treatment, and outcomes: the balANZ trial. Petit Dial Int,2012,32(5) :497-506.

同被引文献24

引证文献5

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部